Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
166,6 USD | +0,56% | +6,01% | -7,35% |
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Filtration
54,4
%
| 496 | 61,9 % | 348 | 54,4 % | -29,87% |
Chromatography
19,8
%
| 132 | 16,4 % | 127 | 19,8 % | -3,84% |
Proteins
16,2
%
| 114 | 14,3 % | 103 | 16,2 % | -9,50% |
Process Analytics
8,9
%
| 54 | 6,7 % | 57 | 8,9 % | +6,18% |
Other Product
0,6
%
| 6 | 0,7 % | 4 | 0,6 % | -35,76% |
Royalty and Other
0,1
%
| 0 | 0,0 % | 0 | 0,1 % | +8,50% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
North America
44,0
%
| 345 | 43,0 % | 281 | 44,0 % | -18,45% |
Europe
37,0
%
| 297 | 37,0 % | 236 | 37,0 % | -20,31% |
APAC
19,0
%
| 160 | 20,0 % | 121 | 19,0 % | -24,29% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 01/05/14 |
Olivier Loeillot
PSD | President | 54 | 02/10/23 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 25/09/23 |
James Bylund
COO | Chief Operating Officer | 61 | 01/03/20 |
Ralf Kuriyel
CTO | Chief Tech/Sci/R&D Officer | 66 | 18/10/16 |
Sondra S. Newman
IRC | Investor Relations Contact | - | - |
Jaime Humara
SAM | Sales & Marketing | - | 01/11/22 |
Kola Otitoju
PRN | Corporate Officer/Principal | - | - |
Christine Gebski
PRN | Corporate Officer/Principal | 56 | 01/01/15 |
Vikas Gupta
PRN | Corporate Officer/Principal | - | 01/03/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 01/09/05 |
Director/Board Member | 58 | 12/06/14 | |
Martin Madaus
BRD | Director/Board Member | 64 | 06/02/23 |
Glenn Muir
BRD | Director/Board Member | 65 | 01/10/15 |
Carrie Manner
BRD | Director/Board Member | 50 | 11/06/20 |
Tony Hunt
CEO | Chief Executive Officer | 60 | 01/05/14 |
Director/Board Member | 66 | 26/05/22 | |
Rohin Mhatre
BRD | Director/Board Member | 59 | 01/03/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 55 838 548 | 52 159 662 ( 93,41 %) | 0 | 93,41 % |
Coordinate società
Repligen Corp.
41 Seyon Street Building 1, Suite 100
02453, Waltham
+781 250 0111
http://www.repligen.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Repligen Europe BV
Repligen Europe BV Medical DistributorsDistribution Services Part of Repligen Corp., Repligen Europe BV is a Dutch company that wholesales medical and dental instruments. The private company is located in Netherlands. |
Medical Distributors
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-7,35% | 9,3 Mrd | |
-2,31% | 187 Mrd | |
-3,20% | 106 Mrd | |
-5,04% | 66,9 Mrd | |
+0,20% | 49,45 Mrd | |
+17,29% | 48 Mrd | |
+4,06% | 40,84 Mrd | |
+2,36% | 26,25 Mrd | |
+2,07% | 26,48 Mrd | |
+12,96% | 24,62 Mrd |
- Borsa valori
- Azioni
- Azione RGEN
- Società Repligen Corporation